Matches in Nanopublications for { ?s ?p "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622448.RACFCzo4v7T3TbXroNEFE6P7aNQUk5Eg7LLDClgpVKCZE130_provenance.
- assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP949493.RASJ7lVxxtwWCevuAuyZsdu6DPOUoUGbrOhBBpujdQGpM130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949493.RASJ7lVxxtwWCevuAuyZsdu6DPOUoUGbrOhBBpujdQGpM130_provenance.
- assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243591.RAhtY5Vb2CcNIlozS5y5ksMyYYM6l6NM8VZOxnmN3ZhT8130_provenance.
- NP393729.RAuCvbrdlRf83SeMLPYKoXzGQJXwZwXyU5Qld_C5E4LR8130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393729.RAuCvbrdlRf83SeMLPYKoXzGQJXwZwXyU5Qld_C5E4LR8130_provenance.
- NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_assertion description "[In particular, transgenic mice overexpressing apoA-II exhibit hypertriglyceridemia, increased body fat, and insulin resistance, whereas apoA-II-null mice have decreased triglycerides and increased insulin sensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393727.RA19nWt-hYVvBzLr3UG6YvuOhhCZ-nKd_Tx6P2ZPHM0do130_provenance.